185 related articles for article (PubMed ID: 19912992)
1. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes.
Garten A; Petzold S; Barnikol-Oettler A; Körner A; Thasler WE; Kratzsch J; Kiess W; Gebhardt R
Biochem Biophys Res Commun; 2010 Jan; 391(1):376-81. PubMed ID: 19912992
[TBL] [Abstract][Full Text] [Related]
2. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
Chang YC; Chang TJ; Lee WJ; Chuang LM
Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
[TBL] [Abstract][Full Text] [Related]
3. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
[TBL] [Abstract][Full Text] [Related]
4. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine.
Sommer G; Garten A; Petzold S; Beck-Sickinger AG; Blüher M; Stumvoll M; Fasshauer M
Clin Sci (Lond); 2008 Jul; 115(1):13-23. PubMed ID: 19016657
[TBL] [Abstract][Full Text] [Related]
5. Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease.
Moschen AR; Geiger S; Gerner R; Tilg H
Mutat Res; 2010 Aug; 690(1-2):95-101. PubMed ID: 19583971
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats.
Sun Q; Li L; Li R; Yang M; Liu H; Nowicki MJ; Zong H; Xu J; Yang G
Ann Med; 2009; 41(4):311-20. PubMed ID: 19263259
[TBL] [Abstract][Full Text] [Related]
7. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly.
Olarescu NC; Ueland T; Lekva T; Dahl TB; Halvorsen B; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2012 Apr; 97(4):1355-62. PubMed ID: 22319029
[TBL] [Abstract][Full Text] [Related]
8. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
10. Nampt and its potential role in inflammation and type 2 diabetes.
Garten A; Petzold S; Schuster S; Körner A; Kratzsch J; Kiess W
Handb Exp Pharmacol; 2011; (203):147-64. PubMed ID: 21484571
[TBL] [Abstract][Full Text] [Related]
11. Nampt/PBEF/visfatin upregulation in colorectal tumors, mirrored in normal tissue and whole blood of colorectal cancer patients, is associated with metastasis, hypoxia, IL1β, and anemia.
Neubauer K; Misa IB; Diakowska D; Kapturkiewicz B; Gamian A; Krzystek-Korpacka M
Biomed Res Int; 2015; 2015():523930. PubMed ID: 26075243
[TBL] [Abstract][Full Text] [Related]
12. Nampt/PBEF/Visfatin: a new player in beta cell physiology and in metabolic diseases?
Tanaka T; Nabeshima Y
Cell Metab; 2007 Nov; 6(5):341-3. PubMed ID: 17983577
[TBL] [Abstract][Full Text] [Related]
13. Diurnal rhythm of circulating nicotinamide phosphoribosyltransferase (Nampt/visfatin/PBEF): impact of sleep loss and relation to glucose metabolism.
Benedict C; Shostak A; Lange T; Brooks SJ; Schiöth HB; Schultes B; Born J; Oster H; Hallschmid M
J Clin Endocrinol Metab; 2012 Feb; 97(2):E218-22. PubMed ID: 22090280
[TBL] [Abstract][Full Text] [Related]
14. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans.
Friebe D; Neef M; Kratzsch J; Erbs S; Dittrich K; Garten A; Petzold-Quinque S; Blüher S; Reinehr T; Stumvoll M; Blüher M; Kiess W; Körner A
Diabetologia; 2011 May; 54(5):1200-11. PubMed ID: 21298414
[TBL] [Abstract][Full Text] [Related]
15. Association of increased visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Silva C; Rotellar F; Cienfuegos JA; Salvador J; Frühbeck G
Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):245-53. PubMed ID: 20106640
[TBL] [Abstract][Full Text] [Related]
16. Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease.
Dahl TB; Haukeland JW; Yndestad A; Ranheim T; Gladhaug IP; Damås JK; Haaland T; Løberg EM; Arntsen B; Birkeland K; Bjøro K; Ulven SM; Konopski Z; Nebb HI; Aukrust P; Halvorsen B
J Clin Endocrinol Metab; 2010 Jun; 95(6):3039-47. PubMed ID: 20392873
[TBL] [Abstract][Full Text] [Related]
17. The role of visfatin (PBEF/Nampt) in pregnancy complications.
Pavlová T; Novák J; Bienertová-Vašků J
J Reprod Immunol; 2015 Nov; 112():102-10. PubMed ID: 26451650
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity.
Jacques C; Holzenberger M; Mladenovic Z; Salvat C; Pecchi E; Berenbaum F; Gosset M
J Biol Chem; 2012 Apr; 287(18):15100-8. PubMed ID: 22399297
[TBL] [Abstract][Full Text] [Related]
19. Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly - results from the PolSenior substudy.
Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Grodzicki T; Więcek A; Chudek J
J Am Soc Hypertens; 2015 Jan; 9(1):1-8. PubMed ID: 25537462
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like effects of visfatin on human osteoblasts.
Xie H; Tang SY; Luo XH; Huang J; Cui RR; Yuan LQ; Zhou HD; Wu XP; Liao EY
Calcif Tissue Int; 2007 Mar; 80(3):201-10. PubMed ID: 17340225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]